The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke. N Engl J Med1995; 333:1581–7.
2.
WahlgrenN, AhmedN, DávalosA,Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet2007; 369:275–82.
3.
HackeW, KasteM, FieschiC,Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European cooperative acute stroke study (ECASS). JAMA1995; 274:1017–25.
4.
HackeW, KasteM, FieschiC,Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet1998; 352:1245–51.
5.
HackeW, KasteM, BluhmkiE,, ECASS Investigators Thrombolysis with alteplase 3 to 4·5 hours after acute ischemic stroke. N Engl J Med2008; 359:1317–29.
6.
SaqqurM, TsivgoulisG, MolinaCA,, for the CLOTBUST Investigators Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study. Neurology2008; 71:1304–12.
